Latest News

Check Back for the Latest News About Paragonix Technologies

News

Legacy of Hope Performs First Time Use and Clinical Support of Advanced Preservation Technology for Thoracic and Abdominal Organs

CAMBRIDGE, MASSACHUSETTS – January 11, 2022 – Paragonix Technologies, Inc., a leading provider of donor organ preservation and transport systems, announced the first time, combination use of LIVERguard™ and Paragonix SherpaPak® to provide advanced preservation for a heart and liver from the same donor. Legacy of Hope, an Alabama-based Organ Procurement Organization,

Read More »

Paragonix Expands Organ Donor Pool With New NRP-DCD Method

Paragonix Technologies, a leading provider of donor organ preservation and transport systems, collaborates with University of Nebraska to increase organ donor reserve. From Mass Device – Medical Design & Outsourcing  Paragonix Technologies is collaborating with the University of Nebraska Medical Center on a method to advance heart transplantation utilizing DCD (donation after circulatory

Read More »

Paragonix leads the transport of organs with liver and heart milestones

Paragonix Technologies, a leading provider of donor organ preservation and transport systems, has recently launched a new donor liver preservation system (LIVERguard) and a global liver registry. From The Health Guild The LIVERguard system provides a state-of-the-art highly controlled environment for hypothermic preservation of the liver, along with real-time digital

Read More »

Paragonix Leads Organ Transportation with Liver and Heart Milestones

Paragonix Technologies, a leading provider of donor organ preservation and transport systems, recently launched a new donor liver preservation system (LIVERguard) and global liver registry. From Medgadget The LIVERguard System provides a highly controlled, state-of-the art environment for hypothermic liver preservation, coupled with real-time digital monitoring to safeguard a donor

Read More »

Hypothermic Donor Organ Preservation Provider Paragonix Announces First-in-Human Use of Investigational NRP-DCD Method Using SherpaPak by University of Nebraska Medical Center

CAMBRIDGE, MASSACHUSETTS – December 8, 2021 – Paragonix Technologies, a hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by the University of Nebraska Medical Center to recover a donor heart and transport it utilizing the Paragonix SherpaPak® System. From CathLab Digest This novel

Read More »